ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 381 | Rec_0000375 | Temporin-1DRb |
NFLGTLVNLAKKIL |
Rana draytonii [Animal] |
Antimicrobial, Antifungal |
- |
- | Qualitative functional evidence |
16307827 | - |
YES |
| 382 | Rec_0000376 | Gaduscidin-1 [H11A] |
FIHHIIGWISAGVRAIHRAIH |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Escherichia coli MG1655 |
16 μM | MBC |
33770667 | - |
YES |
| 383 | Rec_0000377 | W4A |
RWRWWWRWRA |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram-positive, Anti-Gram-negative |
Staphylococcus aureus 43300 |
2 μM | MIC |
31687796 | - |
YES |
| 384 | Rec_0000378 | Unnamed |
RPKPQQFFGLM |
not reported [other] |
Antibacterial, Antimicrobial, Antifungal, Drug Delivery Vehicle, Anti-Gram-positive, Anti-Gram-negative, Blood-Brain Barrier |
- |
- | - |
18957441 | - |
NO |
| 385 | Rec_0000379 | Beta(A-12) |
KWLKKWLKWLKK |
Synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram-positive, Anti-Gram-negative |
Ciprofloxacin resistant Staphylococcus aureus |
256 μg/mL | MIC |
29310083 | - |
YES |
| 386 | Rec_0000380 | Unnamed |
FLWWLFKWAWK |
not reported [other] |
Anticancer, Antimicrobial |
- |
- | - |
25270878 | - |
NO |
| 387 | Rec_0000381 | Angiotensin I-converting enzyme inhibitor 3 |
IWHHT |
Katsuwonus pelamis [Animal] |
Enzyme inhibitory, ACE inhibitory |
Angiotensin-converting enzyme (ACE) |
5.1 μM | IC50 |
- | - |
YES |
| 388 | Rec_0000382 | EXPB1_ORYSJ |
APKGAGPKDNGGACGYKDVDKAPFLGMNSCGNDPIFKDGKGCGSCFEIKCGIIDTQFRRVKCKYPADTKITFHIEKASNPNYLALLVKYVAGDGDVVEVEIKEKGSEEWKALKESWGAIWRIDTPKPLKGPFSVRVTTEGGEKIIAEDAIMASSSLLLACVVVAAMVSAVSCGPPKVPPGPNITTSYGDKWLEAKATWYGPDGWKADSVYKSNVQAKSKPEACSDKPALIHVTDMNDEPIAAYHFDLSGLAFGAMAKDGKDEELRKA |
Oryza sativa subsp. Japonica [Plant] |
Signaling |
- |
- | - |
- | - |
NO |
| 389 | Rec_0000383 | Pre-baseplate central spike protein Gp5 (Pre-Gp5) (Peptidoglycan hydrolase gp5) (EC 3.2.1.17) [Cleaved into: Baseplate central spike protein Gp5* (Mature Gp5); Gp5C] |
MEMISNNLNWFVGVVEDRMDPLKLGRVRVRVVGLHPPQRAQGDVMGIPTEKLPWMSVIQPITSAAMSGIGGSVTGPVEGTRVYGHFLDKWKTNGIVLGTYGGIVREKPNRLEGFSDPTGQYPRRLGNDTNVLNQGGEVGYDSSSNIIQDSNLDTAINPDDRPLSEIPTDDNPNMSMAEMLRRDEGLRLKVYWDTEGYPTIGIGHLIMKQPVRDMAQINKVLSKQVGREITGNPGSITMEEATALFERDLADMQRDIKSHSKVGPVWQAVNRSRQMALENMAFQMGVGGVAKFNTMLTAMLAGDWEKAYKAGRDSLWYQQTKGRASRVTMIILTGNLESYGVEVKTPARSLSAMAATVAKSSDPADPPIPNDSRILFKEPVSSYKGEYPYVHTMETESGHIQEFDDTPGQERYRLVHPTGTYEEVSPSGRRTRKTVDNLYDITNADGNFLVAGDKKTNVGGSEIYYNMDNRLHQIDGSNTIFVRGDETKTVEGNGTILVKGNVTIVVEGNADITVKGDATNLVEGNQTNTVNGNLSWKVAGTVDWDVGGDWTEKMASMSSISSGQYTIDGSRIDIG |
Escherichia phage vB_EcoM_G2540 [Virus] |
Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase, Non-hemolytic |
- |
- | - |
- | - |
NO |
| 390 | Rec_0000384 | Xentry peptides |
ICIR |
Protein derived [Animal] |
Antimicrobial, Anticancer |
- |
- | - |
24811205 | - |
NO |
| 391 | Rec_0000385 | Cecropin-P1 (1-9) |
WLSKTAKKL |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Salmonella typhimurium ATCC 7731 |
128 μM | MIC |
29266746 | - |
YES |
| 392 | Rec_0000386 | VIRIP[A13,A15] |
LEAIPMSIPPEVAFAKPFVF |
synthetic construct [Synthetic] |
Antiviral, Anti-HIV-1, Entry inhibition |
HIV-1 |
3.45±0.44 μM | IC50 |
17448989 | - |
YES |
| 393 | Rec_0000387 | Lysozyme (EC 3.2.1.17) |
MQVLNSQRKAFLDMVAWSEGTDNGRQPTRNHGYDVIVGGELFTDYSDHPRKLVTLNPKLKSTAAGRYQLLSRWWDAYRNQLGLKDFSPKSQDAVALQQIKERGALPMIDRGDIRQAIDRCSNIWASLPGAGYGQYEHKIGDLIARFKEAGGVVNEVEL |
Salmonella enterica I [Bacterium] |
Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase, Non-hemolytic |
- |
- | Qualitative functional evidence |
- | - |
NO |
| 394 | Rec_0000388 | Gamma-SG neuropeptide |
TMSFSPRL |
Bombyx mori [Animal] |
Hormone, Endocrine, Neuropeptide, Neuromodulator |
- |
- | - |
8475067 | - |
YES |
| 395 | Rec_0000389 | Lysozyme (EC 3.2.1.17) |
MNAKIRYGLSAAVLALIAVGAPAPDILDQFLDEKEGNHTTAYRDGSGIWTICRGATMVDGKPVFPGMKLSKEKCDQVNAIERDKALAWVEKNIKVALSEPQKAGIASFCPYNIGPGKCFPSTFYKRINAGDRRGACEAIRWWIKDGGRDCRIRSNNCYGQVSRRDQESALACWGIDR |
Escherichia coli [Bacterium] |
Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase, Non-hemolytic |
- |
- | - |
- | - |
NO |
| 396 | Rec_0000390 | Unnamed |
CLAGLVFVSEADPVSTDEDKCPLMVKVL |
not reported [other] |
Metabolic regulation, Hormonal activity |
- |
- | - |
34478499 | - |
NO |
| 397 | Rec_0000391 | Unnamed |
SSAAAPFPL |
Homo sapiens [Animal] |
Anticancer |
non-small cell lung cancer; HLA-C*03:04 |
0.02322 μM | Predicted HLA-I binding |
30556813 | - |
NO |
| 398 | Rec_0000392 | BacR |
RRLCRIVVIRVCRR |
synthetic construct [Synthetic] |
Antimicrobial,Antibacterial,Anti-Gram-positive,Anti-Gram-negative |
Streptococcus mitis |
0.5 μg/mL | MIC |
10223951 | - |
YES |
| 399 | Rec_0000393 | Unnamed |
NLVSGLIEARKYLEQLHRKLKNRKV |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
- |
- | - |
- | US 10723764 B2 |
NO |
| 400 | Rec_0000394 | Unnamed |
TKETETEAPAAPAEGEKPAE |
not reported [other] |
Anti-inflammatory |
- |
- | T cell assay |
29636690 | - |
NO |